vimarsana.com

Latest Breaking News On - Arrowhead pharmaceuticals inc - Page 2 : vimarsana.com

RNA Inhibitor Is Shown Safe and Effective in Reduc

Arrowhead Pharmaceuticals Presents New Phase 2 Data of Plozasiran in Patients with Mixed Hyperlipidemia

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Down 2 6%

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report)’s stock price dropped 2.6% on Tuesday . The stock traded as low as $24.24 and last traded at $24.24. Approximately 37,306 shares changed hands during trading, a decline of 97% from the average daily volume of 1,348,370 shares. The stock had previously closed at $24.88. Analyst Ratings […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.